Ohio Board of Pharmacy bans sale of hydroxychloroquine to treat coronavirus
Jul 29, 2020 / 06:57 PM EDT / Updated: Jul 29, 2020 / 08:05 PM EDTCOLUMBUS (WCMH) — Beginning July 30, a Ohio Board of Pharmacy rule goes into effect banning the dispensing of hydroxychloroquine for the treatment or prevention of COVID-19.
The rule prohibits pharmacies from selling or dispensing hydroxychloroquine and chloroquine for use as a coronavirus treatment without approval from the board’s executive director. It also specifies that all prior approvals for the drugs are no longer applicable.
The rule does not apply to board-approved clinical trials. Participants must have documentation that they are part of such a trial. It does not apply to prescriptions to treat other conditions.
The rule reads:
4729:5-5-21 Prescription requirements for chloroquine and hydroxychloroquine. . . .
https://www.nbc4i.com/news/local-news/ohio-board-of-pharmacy-bans-dispensing-of-hydroxychloroquine-to-treat-coronavirus/It is better to deny medication that could save a dying person's life than to let them have something that was approved for medical use by the FDA over half a century ago.